VG Life Sciences Inc.
VGLS
$0.00
$0.000.00%
| 09/30/2015 | 06/30/2015 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -12.52% | -10.17% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -12.84% | -7.76% | |||
| Operating Income | 12.84% | 7.76% | |||
| Income Before Tax | 27.37% | 4.36% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 27.37% | 4.36% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 0.00% | 0.00% | |||
| Net Income | 27.54% | 4.38% | |||
| EBIT | 12.84% | 7.76% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 43.06% | 26.15% | |||
| Normalized Basic EPS | 43.08% | 26.14% | |||
| EPS Diluted | 43.06% | 26.15% | |||
| Normalized Diluted EPS | 43.08% | 26.14% | |||
| Average Basic Shares Outstanding | 27.73% | 29.55% | |||
| Average Diluted Shares Outstanding | 27.73% | 29.55% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
